Clavis Pharma

Developer of novel small molecule therapeutics for cancer

placeOslo, Oslo, Norway calendar_todayFounded 2001 language clavispharma.com

Innovation

12 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 354 times.

YearFilings
20128
20136
20143
20151
20161
20171
20191

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Private equity125%
Other / undisclosed250%
Coming soon